Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest autoimmune disease Stories

2013-07-05 23:03:26

Medical Professionals seeking advanced medical education will gather at the JW Marriott- LA Live in August for Gut, Brain, and Autoimmune Disorders course Boca Raton, Florida (PRWEB) July 05, 2013 The Symposium will provide attendees with the opportunity to understand the connections between food and disease manifestations. Another main focus will be GI and neurological disorders and other organ systems including the cardiovascular system. Upon completion, participants of this course...

2013-06-27 12:27:52

SEATTLE, June 27, 2013 /PRNewswire/ -- Adaptive Biotechnologies announced today that it has signed an agreement with Biogen Idec for the study of the immune repertoire and the search for immunological biomarkers in difficult to treat autoimmune diseases. (Logo: http://photos.prnewswire.com/prnh/20120103/SF28632LOGO) Under the collaboration, Adaptive's proprietary immune profiling assay, immunoSEQ, will be used to characterize the immune repertoire of patient samples with...

2013-06-26 16:24:26

--Novel Approach May Have Potential to Revolutionize Treatment of Certain Autoimmune Diseases By Selectively Neutralizing Destructive Self-Antigens While Leaving Rest of Immune System Unaffected-- PORTOLA VALLEY, Calif., June 26, 2013 /PRNewswire/ -- Tolerion Inc., today announced the publication of results from a Phase 2 trial demonstrating that lead product TOL-3021 may have the potential to alleviate or even shut down the destructive disease process in type 1...

2013-06-13 08:27:27

-- Enrollment Expected to Begin Next Month -- SEATTLE, June 13, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has obtained regulatory clearance to start the Phase 1 clinical trial evaluating OMS721, the Company's lead human monoclonal antibody from its mannan-binding lectin-associated serine protease-2 (MASP-2) program. The first clinical trial with OMS721 will be conducted in Europe and will evaluate the safety, tolerability, pharmacodynamics and...

2013-05-28 08:27:55

-- Phase 1 Clinical Trial Expected to Begin Early Next Quarter -- SEATTLE, Wash., May 28, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has filed a Clinical Trial Application (CTA) with European regulators to initiate clinical trials evaluating OMS721, the Company's lead human monoclonal antibody from its mannan-binding lectin-associated serine protease-2 (MASP-2) program. The lead indication for OMS721 will be atypical hemolytic uremic syndrome...

2013-05-20 20:22:11

Human and Vet Researchers to Convene in Louisville, KY on 'Fibrosis Across Species' LOUISVILLE, Ky., May 20, 2013 /PRNewswire-USNewswire/ -- Researchers from human and veterinary medicine want to know more about the lung disease that is killing horses, including thoroughbred horses and other domestic animals, just as it's claiming an increasing number of human lives - and are hoping the animals will hold a key to finding treatments faster for both. Pulmonary Fibrosis (PF) is a...

2013-05-20 08:27:33

BETHESDA, Md., May 20, 2013 /PRNewswire/ -- TNI BioTech, Inc. (OTCQB: TNIB), a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using patented immunotherapy, announced its common stock is trading on the OTC Markets' OTCQB marketplace under the ticker symbol "TNIB" commencing May 17, 2013. Investors will be able to view the real-time Level II stock quotes for TNIB at http://www.otcmarkets.com/stock/TNIB/quote. Noreen...

Coffee Lowers Risk Of Autoimmune Liver Disease
2013-05-19 07:29:04

redOrbit Staff & Wire Reports - Your Universe Online Regular coffee consumption has been linked to a reduced risk of the autoimmune liver disease primary sclerosing cholangitis (PSC), according to a study that will be presented by Mayo Clinic researchers at the Digestive Disease Week 2013 conference in Orlando, Florida on Monday. According to the Minnesota-based medical center, PSC is a disease of the bile ducts, which can result in inflammation and subsequent duct obstruction...

2013-05-16 08:26:58

LA JOLLA, Calif. and SHANGHAI, May 16, 2013 /PRNewswire/ -- RuiYi Inc. announced today that it has entered into an exclusive license and collaborative development agreement with Genor BioPharma for the development of RYI-008 in China. RYI-008 is a novel anti-IL-6 monoclonal antibody with a unique pharmacologic profile that has the potential to define a new paradigm in the treatment of autoimmune diseases and cancer. "RYI-008, with its unprecedented femtamolar potency and amazing long...

2013-05-14 23:25:50

May is Celiac Awareness Month and local San Antonio internal medicine practice, Digestive & Liver Disease Center of San Antonio, advises on the disorder. San Antonio, TX (PRWEB) May 14, 2013 Digestive & Liver Disease Center of San Antonio encourages the public to advocate for Celiac Awareness Month in May. Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley and rye. An estimated 1 in 141 Americans has celiac disease, yet...